Diuretic weight-cutting / masking agents
Metabolic Health · Diuretic / masking agent
Tier D
High-risk evidence profile
Bottom line
Read Off Label grades Diuretic weight-cutting / masking agents as D (2.9/10) based on weak evidence, med benefit magnitude, and a high-risk safety profile.
Its high-risk evidence profile reflects a Safety score of 2/10; reported benefits and harms can differ by indication, dose, route, duration, and population.
WADA coverage: acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, metolazone, thiazides, bendroflumethiazide, chlorothiazide, hydrochlorothiazide, torasemide, triamterene, xipamide, vaptans, conivaptan, mozavaptan, tolvaptan, albumin, dextran, hydroxyethyl starch, mannitol, desmopressin and probenecid.
Studied, labeled, or reported-use context: Clinical dosing varies by drug and indication; no weight-cutting dose — Rx/OTC/status varies; WADA S5 prohibited at all times except listed exceptions; not individualized guidance.
What the evidence says
WADA coverage: acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, metolazone, thiazides, bendroflumethiazide, chlorothiazide, hydrochlorothiazide, torasemide, triamterene, xipamide, vaptans, conivaptan, mozavaptan, tolvaptan, albumin, dextran, hydroxyethyl starch, mannitol, desmopressin and probenecid. Drospirenone, pamabrom, topical ophthalmic carbonic anhydrase inhibitors, dorzolamide, brinzolamide and dental felypressin are WADA-listed exceptions, not added as prohibited-performance interventions.
Mechanism
Diuretics can rapidly reduce scale weight through water loss and some masking agents alter urinary excretion; neither is fat loss, and risk rises quickly with dehydration or electrolyte shifts.
Studied, labeled, or reported dose & route
Clinical dosing varies by drug and indication; no weight-cutting dose
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Diuretic weight-cutting / masking agents's effects?
- Read Off Label rates the evidence for Diuretic weight-cutting / masking agents as Weak and the benefit magnitude as med, producing an overall grade of D (2.9/10). WADA coverage: acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, metolazone, thiazides, bendroflumethiazide, chlorothiazide, hydrochlorothiazide, torasemide, triamterene, xipamide, vaptans, conivaptan, mozavaptan, tolvaptan, albumin, dextran, hydroxyethyl starch, mannitol, desmopressin and probenecid.
- What safety findings are reported for Diuretic weight-cutting / masking agents?
- Diuretic weight-cutting / masking agents has a high risk profile in the database. High (dehydration, electrolyte derangement, arrhythmia, kidney injury, hypotension, masking-drug legal risk) Legal status: Rx/OTC/status varies; WADA S5 prohibited at all times except listed exceptions.
- What does the low Safety score for Diuretic weight-cutting / masking agents represent?
- The Safety score is 2/10. It records the substantial harms described for one or more use contexts; the Benefit score, indication, dose, route, duration, population, and legal status remain separate parts of the evidence profile.
- What doses or routes are reported for Diuretic weight-cutting / masking agents?
- Clinical dosing varies by drug and indication; no weight-cutting dose This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Diuretic weight-cutting / masking agents work?
- Diuretics can rapidly reduce scale weight through water loss and some masking agents alter urinary excretion; neither is fat loss, and risk rises quickly with dehydration or electrolyte shifts.
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.